Kezar Life Sciences Inc

-0.02 (-1.75%)
: $1.08 -0.04 (-3.57%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)81.42M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.5 Million
Adjusted EPS-$0.36
See more estimates
10-Day MA$1.19
50-Day MA$1.67
200-Day MA$3.70
See more pivots

Kezar Life Sciences Inc Stock, NASDAQ:KZR

4000 Shoreline Court, Suite 300, South San Francisco, California 94080
United States of America
Phone: +1.650.822.5600
Number of Employees: 84


Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.